M. Y. Adamu

Dr. M. Y. Adamu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Thermal Science
Verified
Journal Article
Open access
PDF file
MAM. Y. Adamu
M. Y. Adamu
POPeter Ogenyi
Peter Ogenyi
In this paper, new approach to parameterized homotopy perturbation method is presented to solve non-oscillatory problems. In contrast to the classical version of the homotopy method, optimal value of ? is identified and used to obtain approximate solutions. The new approach is powerful as it effectively handled non-oscillatory problems and gives results with the smallest known errors.

29 March 2024 in Optical and Quantum Electronics
Verified
Journal Article
Closed access
PDF file
SASaad althobaiti
Saad althobaiti
RNRahmatullah Nuruddeen
Rahmatullah Nuruddeen
MAM. Y. Adamu
M. Y. Adamu
Gómez Aguilar José FranciscoGómez Aguilar José Francisco
Gómez Aguilar José Francisco

7 March 2023 in Fractal and Fractional
Verified
Journal Article
Open access
PDF file
DYDauda Gulibur Yakubu
Dauda Gulibur Yakubu
AMAbdulhameed Mohammed
Abdulhameed Mohammed
ATAdamu Garba Tahiru
Adamu Garba Tahiru
SKSaidu Abubakar Kadas
Saidu Abubakar Kadas
MAM. Y. Adamu
M. Y. Adamu
In the search for causes and cures of cancer diseases, many mathematical models developed have resulted in systems of nonlinear stiff ordinary differential equations. With these models, many numerical estimates of biological knowledge of the parameters have been obtained, a number of phenomena interpreted, and predictions were made in order to gain further knowledge of cancer development and possible treatment. In this study, numerical simulations of the models were performed using continuous block implicit hybrid methods and the results obtained support the theoretical and clinical findings. We analyzed the interactions among the various tumor cell populations and present the results graphically. From the graphical representation of results, one can clearly see the effects of all the tumor cell populations involved in the competition, as well as the effects of some treatments by the applications of some therapeutic agents which have been heavily used in the clinical treatments of breast cancer. The treatments in the past were mostly conventional chemotherapies, which were used either singly (alone) or in combination with each other or other therapies, and all played vital roles, except for the side effects that these therapies incur in normal tissues and organs. Thus, from recent research works, it is now clear that in many cases they do not represent a complete cure. Therefore, the need to address not only the preventative measures of breast cancer, but also more successful treatment, is clear, and can be successfully achieved to increase the survival rate of breast cancer patients.